Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 134 contracts
Samples: Sales Agreement (Riot Platforms, Inc.), Sales Agreement (Mind Medicine (MindMed) Inc.), Atm Sales Agreement (HeartBeam, Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 127 contracts
Samples: At Market Issuance Sales Agreement (Soligenix, Inc.), Atm Sales Agreement (Predictive Oncology Inc.), Atm Sales Agreement (Predictive Oncology Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 57 contracts
Samples: Sales Agreement (Celldex Therapeutics, Inc.), At the Market Issuance Sales Agreement (Houston American Energy Corp), At Market Issuance Sales Agreement (Ocugen, Inc.)
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 38 contracts
Samples: Sales Agreement (Mawson Infrastructure Group Inc.), Sales Agreement (Pixelworks, Inc), Sales Agreement (Asure Software Inc)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 33 contracts
Samples: Sales Agreement (CorMedix Inc.), At Market Issuance Sales Agreement (CorMedix Inc.), At Market Issuance Sales Agreement (CorMedix Inc.)
Certain Market Activities. Neither the Company, nor any of Subsidiary, nor, to the SubsidiariesCompany’s knowledge, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 28 contracts
Samples: At Market Issuance Sales Agreement (Moleculin Biotech, Inc.), At Market Issuance Sales Agreement (Moleculin Biotech, Inc.), At Market Issuance Sales Agreement (Moleculin Biotech, Inc.)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 25 contracts
Samples: At Market Issuance Sales Agreement (Geron Corp), At Market Issuance Sales Agreement (Geron Corp), At Market Issuance Sales Agreement (Stellus Capital Investment Corp)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 21 contracts
Samples: At Market Issuance Sales Agreement (Gryphon Digital Mining, Inc.), At Market Issuance Sales Agreement (Turning Point Brands, Inc.), At Market Issuance Sales Agreement (LanzaTech Global, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 19 contracts
Samples: Sales Agreement (Perspective Therapeutics, Inc.), Sales Agreement (Semler Scientific, Inc.), Sales Agreement (Apollomics Inc.)
Certain Market Activities. Neither the Company, nor Company or any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 16 contracts
Samples: At the Market Issuance Sales Agreement (RDE, Inc.), At the Market Issuance Sales Agreement (Aclarion, Inc.), At the Market Issuance Sales Agreement (Oragenics Inc)
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor to the knowledge of the Company any of their respective directors, directors or officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act Act, Canadian Securities Laws or otherwise, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 14 contracts
Samples: Underwriting Agreement (Western Copper & Gold Corp), Underwriting Agreement (Northern Dynasty Minerals LTD), Underwriting Agreement (Northern Dynasty Minerals LTD)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 14 contracts
Samples: At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 13 contracts
Samples: Sales Agreement (Volta Inc.), Sales Agreement (Opiant Pharmaceuticals, Inc.), Sales Agreement (Delcath Systems, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 13 contracts
Samples: Atm Sales Agreement (Vision Marine Technologies Inc.), Sales Agreement (Paramount Gold Nevada Corp.), Atm Sales Agreement (MAIA Biotechnology, Inc.)
Certain Market Activities. Neither the Company, nor Company or any of the Subsidiaries, nor any of their respective directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 10 contracts
Samples: At the Market Issuance Sales Agreement (Ault Alliance, Inc.), At the Market Issuance Sales Agreement (SciSparc Ltd.), At the Market Issuance Sales Agreement (Singing Machine Co Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 10 contracts
Samples: Sales Agreement (NightHawk Biosciences, Inc.), At Market Issuance Sales Agreement (Synthetic Biologics, Inc.), At Market Issuance Sales Agreement (Heat Biologics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor to the knowledge of the Company any of their respective directors, directors or officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act Act, Canadian Securities Laws or otherwise, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesUnits.
Appears in 10 contracts
Samples: Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Vista Gold Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 9 contracts
Samples: Sales Agreement (Anixa Biosciences Inc), Sales Agreement (Cyclacel Pharmaceuticals, Inc.), Sales Agreement (Verastem, Inc.)
Certain Market Activities. Neither the Company, Company nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 9 contracts
Samples: At the Market Offering Agreement (Celsion CORP), Sales Agreement (Forty Seven, Inc.), Sales Agreement (Forty Seven, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Distribution Agreement (Tellurian Inc. /De/), Distribution Agreement (Tellurian Inc. /De/), Securities Purchase Agreement (Tellurian Inc. /De/)
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the its Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Sales Agreement (Sunesis Pharmaceuticals Inc), Sales Agreement (Sunesis Pharmaceuticals Inc), Sales Agreement (Sunesis Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, any Subsidiary nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Equity Distribution Agreement (Inspirato Inc), Capital on Demand Sales Agreement (Lexaria Bioscience Corp.), Capital on Demand Sales Agreement (Elicio Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 8 contracts
Samples: Sales Agreement (Lineage Cell Therapeutics, Inc.), Sales Agreement (AgeX Therapeutics, Inc.), Sales Agreement (Lineage Cell Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesOffered Securities.
Appears in 7 contracts
Samples: Placement Agent Agreement (Tellurian Inc. /De/), Placement Agent Agreement (Tellurian Inc. /De/), Underwriting Agreement (Tellurian Inc. /De/)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 6 contracts
Samples: Open Market Sale Agreement (Achieve Life Sciences, Inc.), Investment Agreement (Perspective Therapeutics, Inc.), Investment Agreement (Perspective Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 6 contracts
Samples: Sales Agreement (Array Biopharma Inc), Sales Agreement (Array Biopharma Inc), Sales Agreement (CollabRx, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 6 contracts
Samples: Sales Agreement (eFFECTOR Therapeutics, Inc.), At Market Issuance Sales Agreement (Jakks Pacific Inc), At Market Issuance Sales Agreement (Jakks Pacific Inc)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 5 contracts
Samples: At Market Issuance Sales Agreement (Actinium Pharmaceuticals, Inc.), At the Market Issuance Sales Agreement (Actinium Pharmaceuticals, Inc.), At Market Issuance Sales Agreement (Actinium Pharmaceuticals, Inc.)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 5 contracts
Samples: At Market Issuance Sales Agreement (American Superconductor Corp /De/), At Market Issuance Sales Agreement (Ashford Inc.), At Market Issuance Sales Agreement (Sorrento Therapeutics, Inc.)
Certain Market Activities. Neither To the Company’s knowledge, neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Heat Biologics, Inc.), At the Market Issuance Sales Agreement (Ligand Pharmaceuticals Inc), Sales Agreement (Sucampo Pharmaceuticals, Inc.)
Certain Market Activities. Neither the Company, any Subsidiary nor any of the Subsidiaries, nor any of their respective its directors, officers or or, to the Company’s knowledge, controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Capital on Demand Sales Agreement (Virios Therapeutics, Inc.), Capital on Demand Sales Agreement (NEUROONE MEDICAL TECHNOLOGIES Corp), Capital on Demand Sales Agreement (Ocuphire Pharma, Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Underwriting Agreement (MTBC, Inc.), Underwriting Agreement (MTBC, Inc.), Underwriting Agreement (MTBC, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 4 contracts
Samples: Underwriting Agreement (Mind Medicine (MindMed) Inc.), Underwriting Agreement (Protagonist Therapeutics, Inc), Underwriting Agreement (Protagonist Therapeutics, Inc)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Immucell Corp /De/), Securities Purchase Agreement (Immucell Corp /De/), Securities Purchase Agreement (Transwitch Corp /De)
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor to the knowledge of the Company any of their respective directors, directors or officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization stabilization, maintenance or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (IZEA Worldwide, Inc.), Sales Agreement (IZEA Worldwide, Inc.), Sales Agreement (IZEA Worldwide, Inc.)
Certain Market Activities. Neither the Company, Company nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: At the Market Issuance Sales Agreement (Emerald Oil, Inc.), At the Market Issuance Sales Agreement (Emerald Oil, Inc.), At the Market Issuance Sales Agreement (PostRock Energy Corp)
Certain Market Activities. Neither the Company, nor any None of the SubsidiariesCompany Parties, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Equity Distribution Agreement (Enveric Biosciences, Inc.), Equity Distribution Agreement (Edesa Biotech, Inc.), Equity Distribution Agreement (Edesa Biotech, Inc.)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Sales Agreement (Ardelyx, Inc.), Sales Agreement (Ardelyx, Inc.), Sales Agreement (Signal Genetics, Inc.)
Certain Market Activities. Neither the CompanyCompany nor any Subsidiary, nor to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Capital on Demand Sales Agreement (Monopar Therapeutics), Capital on Demand Sales Agreement (Monopar Therapeutics), Capital on Demand Sales Agreement (Catalyst Biosciences, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 4 contracts
Samples: Open Market Sale Agreement (Protagonist Therapeutics, Inc), Open Market Sale Agreement (Cytosorbents Corp), Open Market Sale Agreement (Protagonist Therapeutics, Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 4 contracts
Samples: Underwriting Agreement (Theratechnologies Inc.), Underwriting Agreement (Protagonist Therapeutics, Inc), Underwriting Agreement (Cellular Biomedicine Group, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares or any Forward Settlement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.)
Certain Market Activities. Neither the Company, nor any of the its Subsidiaries, nor any of their respective directors, officers or controlling persons has have taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Akebia Therapeutics, Inc.), Sales Agreement (Akebia Therapeutics, Inc.), Sales Agreement (Akebia Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Biovie Inc.), Sales Agreement (Titan Pharmaceuticals Inc), At the Market Offering Sales Agreement (Ascent Solar Technologies, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Pdi Inc), Sales Agreement (Unilife Corp), Sales Agreement (Unilife Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons persons, has taken, directly or indirectly, any action designeddesigned to, or that has constituted constituted, or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Lumos Pharma, Inc.), Sales Agreement (Newlink Genetics Corp), Sales Agreement (Newlink Genetics Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designeddesigned to, that has constituted, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Archer Aviation Inc.), Sales Agreement (Rubicon Technologies, Inc.), Sales Agreement (Rubicon Technologies, Inc.)
Certain Market Activities. Neither the Company, nor any of the Material Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has takentaken or will take, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesStock.
Appears in 3 contracts
Samples: Underwriting Agreement (American Superconductor Corp /De/), Underwriting Agreement (American Superconductor Corp /De/), Underwriting Agreement (American Superconductor Corp /De/)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: At the Market Issuance Sales Agreement (Oncogenex Pharmaceuticals, Inc.), At Market Issuance Sales Agreement (Acura Pharmaceuticals, Inc), At Market Issuance Sales Agreement (Omeros Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act, the ASX Listing Rules, the Corporations Act or otherwiseother relevant law, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: Sales Agreement (Alterity Therapeutics LTD), At Market Issuance Sales Agreement (Prana Biotechnology LTD), At the Market Issuance Sales Agreement (Prana Biotechnology LTD)
Certain Market Activities. Neither the Company, nor nor, to the knowledge of the Company, any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: At Market Issuance Sales Agreement (Correvio Pharma Corp.), At Market Issuance Sales Agreement (Cardiome Pharma Corp), At Market Issuance Sales Agreement (Cardiome Pharma Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: At Market Issuance Sales Agreement (Forte Biosciences, Inc.), At Market Issuance Sales Agreement (Forte Biosciences, Inc.), At Market Issuance Sales Agreement (Bionano Genomics, Inc)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the Knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 3 contracts
Samples: At Market Issuance Sales Agreement (Ur-Energy Inc), At Market Issuance Sales Agreement (Ur-Energy Inc), At Market Issuance Sales Agreement (Ur-Energy Inc)
Certain Market Activities. Neither the Company, nor any its Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Verastem, Inc.), Sales Agreement (Verastem, Inc.)
Certain Market Activities. Neither the Company nor, to the Company's knowledge, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (GREENPOWER MOTOR Co INC.), Sales Agreement (ALKALINE WATER Co INC)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Capital on Demand Sales Agreement (Standard Diversified Inc.), Capital on Demand Sales Agreement (Aeglea BioTherapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 2 contracts
Samples: Securities Purchase Agreement (pSivida Corp.), Securities Purchase Agreement (pSivida Corp.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or or, to the Company’s knowledge, controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Caledonia Mining Corp PLC), Sales Agreement (Caledonia Mining Corp PLC)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons persons, has taken, directly or indirectly, any action designeddesigned to constitute, or that has constituted or might reasonably be expected to cause or result inconstituted, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate for the purpose of facilitating the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Spectrum Pharmaceuticals Inc), At Market Issuance Sales Agreement (Spectrum Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, any Subsidiary nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesSecurities.
Appears in 2 contracts
Samples: Underwriting Agreement (CalciMedica, Inc.), Underwriting Agreement (Elicio Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor to the Company’s knowledge, any of the Subsidiariesits affiliates, nor any of their respective directors, officers has taken or controlling persons has takenmay take, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Anworth Mortgage Asset Corp), At Market Issuance Sales Agreement (Anworth Mortgage Asset Corp)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the knowledge of the Company, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Global Medical REIT Inc.), Sales Agreement (Global Medical REIT Inc.)
Certain Market Activities. Neither the Company, nor any of Subsidiary, nor, to the SubsidiariesCompany’s knowledge, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (ViewRay, Inc.), At Market Issuance Sales Agreement (ViewRay, Inc.)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor to the Company’s knowledge, any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Capital on Demand Sales Agreement (Aileron Therapeutics Inc), Capital on Demand Sales Agreement (Aileron Therapeutics Inc)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Coronado Biosciences Inc), At Market Issuance Sales Agreement (Coronado Biosciences Inc)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers officers, or controlling persons Persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At the Market Issuance Sales Agreement (Alzamend Neuro, Inc.), At the Market Issuance Sales Agreement (Alzamend Neuro, Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwiseother applicable law, the stabilization or manipulation of the price of any security of the Company Common Stock to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Trinity Place Holdings Inc.), At Market Issuance Sales Agreement (Teligent, Inc.)
Certain Market Activities. Neither the Company, Company nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At the Market Issuance Sales Agreement (Gastar Exploration Inc.), At the Market Issuance Sales Agreement (ZaZa Energy Corp)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Underwriting Agreement (Biotime Inc), Underwriting Agreement (Asterias Biotherapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the SubsidiariesSubsidiary, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has have taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Pluristem Therapeutics Inc), At Market Issuance Sales Agreement (Pluristem Therapeutics Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or nor, to the Company’s knowledge, any controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Orchids Paper Products CO /DE), Sales Agreement (Orexigen Therapeutics, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares; however, the Company makes no representation with respect to any actions taken by the Agent.
Appears in 2 contracts
Samples: Sales Agreement (Paratek Pharmaceuticals, Inc.), Sales Agreement (Paratek Pharmaceuticals, Inc.)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange 1934 Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Common Shares.
Appears in 2 contracts
Samples: Underwriting Agreement (Stellus Capital Investment Corp), Underwriting Agreement (Stellus Capital Investment Corp)
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (DPW Holdings, Inc.), Sales Agreement (Achillion Pharmaceuticals Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Meta Materials Inc.), Underwriting Agreement (Forte Biosciences, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directorstrustees, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At the Market Issuance Sales Agreement (RAIT Financial Trust), At Market Issuance Sales Agreement (RAIT Financial Trust)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Common Shares and/or Preferred Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Chicken Soup for the Soul Entertainment, Inc.), At Market Issuance Sales Agreement (Chicken Soup for the Soul Entertainment, Inc.)
Certain Market Activities. Neither the Company, nor nor, to the Company’s knowledge, any of the Subsidiaries, nor any of their its respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Open Market Sale Agreement (Ardelyx, Inc.), Open Market Sale Agreement (Ardelyx, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwiseother relevant law, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Tiziana Life Sciences LTD), At Market Issuance Sales Agreement (Sequans Communications)
Certain Market Activities. Neither the Company, nor to the Company’s knowledge, any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Capital on Demand Sales Agreement (ARCA Biopharma, Inc.), Capital on Demand Sales Agreement (ARCA Biopharma, Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or nor, to the Company’s knowledge, any controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (HTG Molecular Diagnostics, Inc), Sales Agreement (HTG Molecular Diagnostics, Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiariesits Subsidiary, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designeddesigned to, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwisesecurities laws applicable to the Company, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 1 contract
Samples: Underwriting Agreement (Zomedica Pharmaceuticals Corp.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Offered Shares.
Appears in 1 contract
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, Subsidiary nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Atm Sales Agreement (AMERICAN BATTERY TECHNOLOGY Co)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directorsmanagement board or supervisory board members, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Sono Group N.V.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, indirectly any action designed, designed to or that has constituted would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement SharesADSs.
Appears in 1 contract
Certain Market Activities. Neither the Company, nor any of the SubsidiariesCompany’s subsidiaries, nor nor, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: At the Market Issuance Sales Agreement (Evolution Petroleum Corp)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (StoneCastle Financial Corp.)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Ordinary Shares.
Appears in 1 contract
Samples: Securities Purchase Agreement (Gorilla Technology Group Inc.)
Certain Market Activities. Neither the Company nor, to the Company’s knowledge, nor any of the SubsidiariesSubsidiary, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Sales Agreement (Stemcells Inc)
Certain Market Activities. Neither the Company, any Subsidiary nor to the Company’s knowledge any of the Subsidiaries, nor any of their respective its directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: Capital on Demand Sales Agreement (HCW Biologics Inc.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Wireless Telecom Group Inc)
Certain Market Activities. Neither the Company, nor any of the Subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Perpetual Preferred Shares.
Appears in 1 contract
Samples: Securities Purchase Agreement (Gorilla Technology Group Inc.)
Certain Market Activities. Neither the Company, nor any of the Subsidiariesits subsidiaries, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Certain Market Activities. Neither the Company, nor any of the Subsidiariessubsidiaries, nor nor, to the Company’s knowledge, any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares; however, the Company makes no representation with respect to any actions taken by the Agent.
Appears in 1 contract
Certain Market Activities. Neither the Company, nor any nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act Act, the applicable TASE listing rules or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (BiondVax Pharmaceuticals Ltd.)
Certain Market Activities. Neither the Company, nor any Subsidiary, nor, to the knowledge of the SubsidiariesCompany, nor any of their respective directors, officers or controlling persons has taken, directly or indirectly, any unlawful action designed, or that has constituted or might reasonably be expected to would cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Placement Shares.
Appears in 1 contract
